Kumaka Industries Ltd

₹ None%

- close price

About

Kumaka Industries Ltd. is engaged in manufacturing pharmaceutical products. The company offers corticosteroids and salts. Kumaka Industries Ltd.

[ edit about ]

[ add key points ]

Website

Market Cap ₹ Cr.
Current Price ₹
High / Low ₹ /
Stock P/E
Book Value ₹
Dividend Yield %
ROCE 9.43 %
ROE %
Face Value ₹ 10.0

Add ratio to table

Edit ratios

Pros

Cons

Earnings include an other income of Rs.6.12 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Edit Columns

Loading peers table ...

Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone




Operating Profit
OPM %

Interest
Depreciation
Profit before tax
Tax %

EPS in Rs
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013
	0.00	0.00	0.00
	2.42	0.42	2.72
Operating Profit	-2.42	-0.42	-2.72
OPM %
	-2.23	-24.46	6.12
Interest	0.00	0.00	0.00
Depreciation	5.25	0.07	0.07
Profit before tax	-9.90	-24.95	3.33
Tax %	0.00%	0.00%	0.00%
	-9.90	-24.95	3.33
EPS in Rs
Dividend Payout %	0.00%	0.00%	0.00%

Compounded Sales Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	344%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013
Equity Capital	21.59	21.59	21.59
Reserves	-200.13	-48.94	-45.48
	240.96	61.91	59.92
	15.79	8.36	7.67
Total Liabilities	78.21	42.92	43.70
	38.25	4.38	2.84
CWIP	0.00	0.00	0.00
Investments	0.71	0.00	2.36
	39.25	38.54	38.50
Total Assets	78.21	42.92	43.70

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013



Net Cash Flow

Ratios

Consolidated Figures in Rs. Crores / View Standalone

	Mar 2011	Mar 2012	Mar 2013
Debtor Days
Inventory Days	34.22	0.00
Days Payable	89.35
Cash Conversion Cycle
Working Capital Days
ROCE %		1.55%	9.43%

Shareholding Pattern

Numbers in percentages

	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021
	87.56%	87.56%	87.56%	87.56%	87.56%	87.56%	87.56%	87.56%	87.55%	87.55%	87.56%	87.56%
	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%
	12.35%	12.35%	12.35%	12.35%	12.35%	12.35%	12.35%	12.35%	12.37%	12.37%	12.35%	12.35%
No. of Shareholders	9,845	9,837	9,837	9,837	9,837	9,837	9,837	9,837	9,837	9,837	9,835	9,835

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Jun 2021
	87.56%	87.56%	87.56%	87.56%	87.56%	87.56%
	0.09%	0.09%	0.09%	0.09%	0.09%	0.09%
	12.35%	12.35%	12.35%	12.35%	12.35%	12.35%
No. of Shareholders	9,845	9,845	9,837	9,837	9,835	9,835

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

All

No data available.

Annual reports

No data available.